Specific mucosal immunity in the pathophysiology of bacterial prostatitis in a rat model.
Mucosal immunity was established in the rat prostate by stimulating the common mucosal system through serosal exposure of formalin-killed Escherichia coli. Immunized but not sham-immunized rats developed bacterial specific IgG and IgA in prostatic fluid, and IgA in urine. Immunized (n = 21) and sham-immunized control rats (n = 30) were challenged by transurethral injection of E. coli into the prostate ducts. Mortality, gross and microscopic pathology, tissue bacterial counts, bacterial associated immunoglobulins, and antibody titers in serum and urine were assessed at 7 days following the challenge. Increased E. coli specific immunoglobulin titers were seen in immunized rats, and E. coli, but not Proteus, found in the prostates of immunized animals were coated with IgG and IgA. Immunization protected against toxaemia and septicemia, seen as a rare complication of acute prostatitis, but did not protect against acute prostatitis, nor alter the degree of tissue damage seen in the rat model.
Ceri
H
H
Department of Biological Sciences, University of Calgary, AB, Canada. ceri@acs.ucalgary.ca
Schmidt
S
S
Olson
M E
ME
Nickel
J C
JC
Benediktsson
H
H
D000208:Acute Disease; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000008:administration & dosage; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D018928:Immunity, Mucosal; D007114:Immunization; D008297:Male; D011472:Prostatitis / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D011511:Proteus / Q000276:immunology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial